Maha Saber is a Patent Agent with patent prosecution experience across a wide range of technologies in the life sciences, including small molecule pharmaceuticals, pharmaceutical formulations, antibodies, protein therapeutics, CRISPR and diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, plant-based therapeutics, and neuroscience methods.
Before joining the firm, Maha completed an Evelyn F. McKnight post-doctoral research fellowship in Neurobiology of Aging and Alzheimer’s Disease in the Translational Neurotrauma Research Program at the University of Arizona and Phoenix Children’s Hospital. Her research focused on brain injury-induced peripheral inflammation and its role in neurodegeneration and peripheral organ damage. Maha’s Ph.D. research investigated neuroinflammation in brain injury and Alzheimer’s disease. In addition, her undergraduate research studied the role of oxytocin in stress and social behavior. Maha has won several awards during her time in academic research, including the Nancy Hirshberg memorial grant (2011), Howard Hughes Research Fellowship (2012-13), Neurotrauma Travel grant for the Neurotrauma society (2015), Graduate Service Award (2016), Broadening Horizons Travel Award, Arizona Alzheimer’s Consortium (2017), Travel Award, 3rd Joint Symposium of the International and National Neurotrauma Societies and AANS/CNS (2018), TEAM-Visa international Travel award (2019), University of Arizona Sursum Fellowship (2019), T32 fellowship award (2018-2020), Burroughs Wellcome Collaborative Fund (2019), International travel award international Neurotrauma Society (2020).
Maha enjoys staying active during the weekends including going hiking and camping, and playing tennis, volleyball, and badminton.